136 related articles for article (PubMed ID: 22766801)
21. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
23. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane.
Shay E; He H; Sakurai S; Tseng SC
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2669-78. PubMed ID: 21228375
[TBL] [Abstract][Full Text] [Related]
25. [Oleanolic acid inhibits proliferation of HUVECs, and inhibits migration and tube formation via VEGF pathway].
Wei JT; Liu M; Liu HZ; Zhao J; Xiao L; Han LJ; Lin XK
Yao Xue Xue Bao; 2012 Nov; 47(11):1457-62. PubMed ID: 23387077
[TBL] [Abstract][Full Text] [Related]
26. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
27. Indirubin derivative E804 inhibits angiogenesis.
Shin EK; Kim JK
BMC Cancer; 2012 May; 12():164. PubMed ID: 22554053
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
[TBL] [Abstract][Full Text] [Related]
29. Impacts of chitosan oligosaccharide (COS) on angiogenic activities.
Huang X; Jiao Y; Zhou C
Microvasc Res; 2021 Mar; 134():104114. PubMed ID: 33232706
[TBL] [Abstract][Full Text] [Related]
30. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro.
Shen AL; Hong F; Liu LY; Lin JM; Zhuang QC; Hong ZF; Peng J
Chin J Integr Med; 2012 Jun; 18(6):431-6. PubMed ID: 22821655
[TBL] [Abstract][Full Text] [Related]
31. A novel caryophyllene type sesquiterpene lactone from Asparagus falcatus (Linn.); structure elucidation and anti-angiogenic activity on HUVECs.
Ghalib RM; Hashim R; Sulaiman O; Mehdi SH; Valkonen A; Rissanen K; Trifunović SR; Khadeer Ahamed MB; Majid AM; Kawamura F
Eur J Med Chem; 2012 Jan; 47(1):601-7. PubMed ID: 22074984
[TBL] [Abstract][Full Text] [Related]
32. Synergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell model.
Qian X; Yan B; Zhou X; Xie L; Wei J; Li R; Yu L; Liu B
Cancer Biother Radiopharm; 2013 Jun; 28(5):385-90. PubMed ID: 23682584
[TBL] [Abstract][Full Text] [Related]
33. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
34. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities.
Li YB; Wang ZQ; Yan X; Chen MW; Bao JL; Wu GS; Ge ZM; Zhou DM; Wang YT; Li RT
Cancer Lett; 2013 Oct; 340(1):88-96. PubMed ID: 23856030
[TBL] [Abstract][Full Text] [Related]
35. Studies on the Anti-Angiogenic Activities of Wild and Cultivated Orostachys japonicus Extracts in Human Umbilical Vein Endothelial Cells.
Cho HD; Lee KW; Won YS; Shin DY; Seo KI
J Food Sci; 2019 Jul; 84(7):1764-1775. PubMed ID: 31218702
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone.
Zhan YH; Huang XF; Hu XB; An QX; Liu ZX; Zhang XQ
Asian Pac J Cancer Prev; 2013; 14(3):1791-5. PubMed ID: 23679275
[TBL] [Abstract][Full Text] [Related]
37. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.
Machado VA; Peixoto D; Costa R; Froufe HJ; Calhelha RC; Abreu RM; Ferreira IC; Soares R; Queiroz MJ
Bioorg Med Chem; 2015 Oct; 23(19):6497-509. PubMed ID: 26344591
[TBL] [Abstract][Full Text] [Related]
39. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
40. Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.
Xu F; Xu H; Wang X; Zhang L; Wen Q; Zhang Y; Xu W
Bioorg Med Chem; 2014 Feb; 22(4):1487-95. PubMed ID: 24440479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
